Siflon Pharma Private Limited, a active private limited company, was established on 27 May 2022 in Anantapur, Andhra Pradesh, India. Engaging in animal pharmaceuticals & healthcare within the hospital and medical care sector, it holds CIN: U24200AP2022PTC121807. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹35.00 Cr and a paid-up capital of ₹34.17 Cr.
It upholds a compliant status. Its leadership includes Ananthaiah Rallapalli (Managing Director), Parvathi Rallapalli (Director), Swetha Rallapalli (Director). Past directors included Ananthaiah Rallapalli, Jatanghi Sriramulu Shilpa, Pooja Mundhra. It holds ₹78.15 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sy.No.25-4, Rachanapalli (Village) Anantapur (Mandal), Anantapur, Andhra Pradesh, 515004.
U24200AP2022PTC121807
121807
27 May 2022
₹35.00 Cr
₹34.17 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Siflon Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ananthaiah Rallapalli | Managing Director | 27 May 2022 | Current |
| Parvathi Rallapalli | Director | 27 May 2022 | Current |
| Swetha Rallapalli | Director | 27 May 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Oct 2023 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Siflon Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Siflon Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹781,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2025 | Sidbi | ₹5.40 Cr | Open |
| 30 Mar 2024 | State Bank Of India | ₹9.75 Cr | Open |
| 08 Dec 2023 | Axis Bank Limited | ₹63.00 Cr | Open |
Explore comprehensive loan charge details -
Siflon Pharma has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Siflon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siflon Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Sidbi amounted to Rs. 5.40 Cr with Charge ID 101117473 was registered on 04 Jul 2025. was recorded as a recent event.
The activity A charge with Axis Bank Limited of Rs. 63.00 Cr registered on 08 Dec 2023 with Charge ID 100868556 was modified on 21 Mar 2025. was completed.
Siflon Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Siflon Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was completed.
A charge with State Bank Of India amounted to Rs. 9.75 Cr with Charge ID 100917062 was registered on 30 Mar 2024. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 63.00 Cr with Charge ID 100868556 was registered on 08 Dec 2023. was completed.
The CIN of Siflon Pharma Private Limited is U24200AP2022PTC121807.
Siflon Pharma Private Limited is headquartered at Sy.No.25-4, Rachanapalli (Village) Anantapur (Mandal), Anantapur, Andhra Pradesh, 515004.
Siflon Pharma Private Limited was incorporated on 27 May 2022.
The current directors of Siflon Pharma Private Limited are
The primary industry of Siflon Pharma Private Limited is Hospital And Medical Care.
Siflon Pharma Private Limited is unlisted.
The authorized capital of Siflon Pharma Private Limited is ₹35.00 Cr, and the paid-up capital is ₹34.17 Cr.
The compliance status of Siflon Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX